Literature DB >> 16514316

Serum creatinine changes in HIV-seropositive patients receiving tenofovir.

Hana M El Sahly, Larry Teeter, Teddy Zerai, Roberto A Andrade, Cesar Munoz, Calista Nnabuife, Rodney Hunter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16514316     DOI： 10.1097/01.aids.0000216386.60481.47

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

1.  Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine.

Authors:  Albert Mwafongo; Kondwani Nkanaunena; Yu Zheng; Evelyn Hogg; Wadzanai Samaneka; Lloyd Mulenga; Abraham Siika; Judith Currier; Shahin Lockman; Michael D Hughes; Mina Hosseinipour
Journal:  AIDS       Date:  2014-05-15       Impact factor: 4.177

2.  Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects.

Authors:  Koen K A Van Rompay; Lucie Durand-Gasselin; Laurie L Brignolo; Adrian S Ray; Kristina Abel; Tomas Cihlar; Abigail Spinner; Christopher Jerome; Joseph Moore; Brian P Kearney; Marta L Marthas; Hans Reiser; Norbert Bischofberger
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

3.  Incidence of Acute Kidney Injury in Patients Coinfected with HIV and Hepatitis C Virus Receiving Tenofovir Disoproxil Fumarate and Ledipasvir/Sofosbuvir in a Real-World, Urban, Ryan White Clinic.

Authors:  Jessica L Michal; Saira Rab; Manish Patel; Alison W Kyle; Lesley S Miller; Kirk A Easley; Aley G Kalapila
Journal:  AIDS Res Hum Retroviruses       Date:  2018-06-19       Impact factor: 2.205
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.